Ciprofloxacin Hydrochloride
Who holds supplier records for Ciprofloxacin Hydrochloride? 13 organisations hold a current record for Ciprofloxacin Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), China (2), Germany (1), Spain (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ciprofloxacin Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ciprofloxacin-hydrochloride
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ciprofloxacin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AARTI DRUGS LTDIndiaCEP Company GMP cert on recordActive DMF 19611 · latest filing Jul 2006
- Bayer AGGermanyCEP Company GMP cert on recordActive DMF 8134 · latest filing Jul 1989
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 13862 · latest filing Nov 1998
- Neuland Laboratories LimitedIndiaCEPActive DMF 13250 · latest filing Sept 1998
- QUIMICA SINTETICA SASpainCEP Company GMP cert on recordActive DMF 8517, 11966 · latest filing Feb 1996
- PHLOW CORPUnited StatesActive DMF 37206 · latest filing Dec 2024
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 17933 · latest filing Dec 2004
- THINQ PHARMA-CRO LTDIndiaActive DMF 30616 · latest filing Jun 2016
- TURTLE PHARMA PRIVATE LTDIndiaActive DMF 33245 · latest filing Oct 2018
- UNION QUIMICO FARMACEUTICA SAActive DMF 17061, 11602 · latest filing Dec 2003
- Zhejiang Huayi Pharmaceutical Co., Ltd.ChinaActive DMF 18083 · latest filing Dec 2004
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordInactive DMF 13072 · latest filing Jul 1998
- ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Ciprofloxacin Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 1998-090 - Rev 15 Ciprofloxacin Hydrochloride | Oct 2026 | — |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2000-405 - Rev 14 Ciprofloxacin Hydrochloride | Sept 2026 | — |
| ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shaoxing | CN | CEP 2019-007 - Rev 05 Ciprofloxacin Hydrochloride, Process 105 | May 2025 | Inspected Mar 2025 Germany |
| BAYER AG Leverkusen | DE | CEP 1998-103 - Rev 07 Ciprofloxacin Hydrochloride | Jan 2025 | — |
| AARTI DRUGS LIMITED Mumbai | IN | CEP 2005-119 - Rev 06 Ciprofloxacin Hydrochloride | Jan 2025 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2003-013 - Rev 08 Ciprofloxacin Hydrochloride | Dec 2024 | — |
| QUIMICA SINTETICA S.A. Alcala De Henares | ES | CEP 1999-096 - Rev 09 Ciprofloxacin Hydrochloride | Oct 2024 | Inspected Apr 2025 Spain |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Ciprofloxacin Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- India · Inactive DMF 24636 · filed Feb 2011
- India · Inactive DMF 21909 · filed Aug 2008
- China · Inactive DMF 20337 · filed Feb 2007
- ZHEJIANG XINHUA PHARMACEUTICAL CO LTDInactive DMF 19876 · filed Oct 2006
- India · Inactive DMF 18558 · filed Jul 2005
- India · Inactive DMF 17786 · filed Oct 2004
- MYLAN LABORATORIES LTDInactive DMF 16544 · filed Apr 2003
- India · Inactive DMF 14905 · filed May 2000
- India · Inactive DMF 14709 · filed Feb 2000
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Ciprofloxacin Hydrochloride is an antibiotic used to treat a variety of bacterial infections. It belongs to the fluoroquinolone class of antimicrobial agents.
Chemical identity
- IUPAC name
- 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrate;hydrochloride
- Canonical SMILES
- C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.O.Cl
- InChIKey
- ARPUHYJMCVWYCZ-UHFFFAOYSA-N
- Synonyms
- Cipro API, bay o 9867 monohydrate, bay-o-9867 monohydrate, cetraxal, ciflox, ciloxan, cipro, ciprobay, ciprofloxacin (as hydrochloride), ciprofloxacin hcl, ciprofloxacin hydrochloride hydrate, ciprofloxacin hydrochloride monohydrate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Fluoroquinolone Antibacterial; Quinolone Antimicrobial
- Mechanism of action
- Cytochrome P450 1A2 Inhibitors
- Chemical structure
- Fluoroquinolones; Quinolones
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ciprofloxacin Hydrochloride?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Ciprofloxacin Hydrochloride: AARTI DRUGS LTD (India), Bayer AG (Germany), Dr. Reddy's Laboratories Ltd. (India), Neuland Laboratories Limited (India), QUIMICA SINTETICA SA (Spain), PHLOW CORP (United States), Taro Pharmaceutical Industries Ltd. (Israel) and THINQ PHARMA-CRO LTD (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ciprofloxacin Hydrochloride Drug Master Files are active?
AARTI DRUGS LTD (DMF 19611), Bayer AG (DMF 8134), Dr. Reddy's Laboratories Ltd. (DMF 13862), Neuland Laboratories Limited (DMF 13250), QUIMICA SINTETICA SA (DMF 8517, 11966), PHLOW CORP (DMF 37206), Taro Pharmaceutical Industries Ltd. (DMF 17933) and THINQ PHARMA-CRO LTD (DMF 30616) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ciprofloxacin Hydrochloride records mean?
9 organisations have only inactive Type II DMFs for Ciprofloxacin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Ciprofloxacin Hydrochloride have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Ciprofloxacin Hydrochloride on the EDQM register, including SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), NEULAND LABORATORIES LIMITED Hyderabad (IN), ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shaoxing (CN), BAYER AG Leverkusen (DE), AARTI DRUGS LIMITED Mumbai (IN) and DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ciprofloxacin Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ciprofloxacin Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.